Case Studies

A Cambridge-based biotech needed a GP site for a Phase IIb RCT of their innovative enzymatic wound gel. We matched them with an experienced practice and managed all regulatory complexity, launching the trial in just 8 weeks.

A pharmaceutical company needed rapid deployment of a rare disease screening programme across multiple practices. We structured it as Quality Improvement, avoiding REC delays while maintaining robust governance and achieving excellent results.

A CE-marked device company needed real-world evidence for Drug Tariff application. We classified it as Service Evaluation rather than research, generating high-quality evidence in just 9 weeks – 70% cost savings versus traditional trials.

A global medtech company developing a next-generation robotic surgical platform needed comprehensive CRO support for their pivotal UK clinical investigation. The system had already completed hundreds of procedures internationally — this is the platform's first UK study. We're managing regulatory compliance, site operations, and data quality throughout this ongoing single-centre study.